Melius Pharma AB
๐ธ๐ชSweden
- Country
- ๐ธ๐ชSweden
- Ownership
- Private
- Established
- 2021-08-01
- Employees
- 1
- Market Cap
- -
- Website
- https://www.meliuspharma.com
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)โข Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)
Phase 2
Active, not recruiting
- Conditions
- Idiopathic Pulmonary FibrosisFibrotic Lung DiseaseCoughIPFChronic CoughCoughing
- Interventions
- Drug: ME-015 (Suplatast Tosilate)Other: Identical placebo
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Melius Pharma AB
- Target Recruit Count
- 40
- Registration Number
- NCT05983471
- Locations
- ๐ฎ๐ณ
Aditya Multi Specialty Hospital, Guntur, Andhra Pradesh, India
๐ฎ๐ณKLE's Dr Prabhakar Kore Hospital & Medical Research Centre, Belgaum, Karnataka, India
๐ฎ๐ณACE Hospital and Research Centre, Pune, Maharashtra, India
News
No news found